real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic uc
Published 2 years ago • 451 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
4:03
real-world outcomes of patients with hcc treated with lenvatinib vs. atezolizumab plus bevacizumab
-
0:49
immunotherapy options for nsclc: nivolumab, pembrolizumab or atezolizumab?
-
4:55
atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma
-
2:57
phase 3 imvigor130 results: atezolizumab in untreated metastatic urothelial carcinoma
-
2:18
final os results of imvigor130: 1l atezolizumab /- chemotherapy in metastatic urothelial carcinoma
-
1:13
a new standard of care for advanced lung cancer: what’s next for pembrolizumab?
-
4:23
keynote-407: 3-year follow-up of pembrolizumab plus chemo in nsclc
-
6:20
atezolizumab for locally advanced or metastatic pd-l1-selected nsclc
-
1:06
fort 05-beat: comparing 1l atezolizumab vs atezolizumab bevacizumab in pd-l1 high nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
2:41
leap-011: exploring first-line pembrolizumab lenvatinib for advanced urothelial carcinoma
-
3:13
frontline atezolizumab for advanced bladder cancer
-
1:41
adjuvant atezolizumab in nsclc
-
4:20
imvigor130 data: atezolizumab alone or with chemo upfront for bladder cancer
-
1:08
dr. james l. gulley on atezolizumab, pembrolizumab, and avelumab's potential uses in bladder cancer
-
3:43
imvigor010: atezolizumab for uc
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
2:30
abacus updates: positive results for preoperative atezolizumab in bladder cancer
-
3:07
enfortumab vedotin in urothelial cancer